OSI Systems OSIS Healthcare Division — Research And Development Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by OSI Systems in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: OSI Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about OSI Systems's healthcare division — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is OSI Systems's healthcare division — research and development expense?
- OSI Systems (OSIS) reported healthcare division — research and development expense of $4.63M in Q1 2026.
- How has OSI Systems's healthcare division — research and development expense changed year-over-year?
- OSI Systems's healthcare division — research and development expense increased by 7.7% year-over-year, from $4.3M to $4.63M.
- What is the long-term trend for OSI Systems's healthcare division — research and development expense?
- Over 2 years (2023 to 2025), OSI Systems's healthcare division — research and development expense has grown at a 2.1% compound annual growth rate (CAGR), from $16.56M to $17.25M.
- What does healthcare division — research and development expense mean?
- Captures the investment in developing new healthcare technologies, products, and clinical solutions. This metric is a critical indicator of the segment's commitment to innovation and its long-term strategy for maintaining a competitive advantage in the medical device market.